… when isoniazid (INH) and rifampin (RMP) are administered in combination than when INH is
… results in production of increased concentrations of a hepatotoxic metabolic product of INH. …

… than among patients receiving standard therapy with isoniazid. One trial was … analysis
included 972 patients treated with rifampin and isoniazid and 954 patients treated with isoniazid. …

… for tuberculosis (TB) and resistance detection for rifampicin and isoniazid. We performed a
systematic review and meta-analyses to assess the diagnostic accuracy of five of these tests …

… In 2014, among all cases of tuberculosis, the average global frequency of isoniazid
resistance without concurrent rifampicin resistance was 9·5% (95% CI 8·0–11·0). In new and …

… for countries with high levels of isoniazid resistance, this systematic review and meta-analysis
identified that extending the duration of rifampicin and increasing the number of effective …

… infected persons compared with the standard regimen of INH could not be determined clearly
in this study. One subgroup analysis involving two trials showed no significant difference in …

… Equal effectiveness for the prevention of TB disease was also reported when 3HP was
compared with 6-month INH, 11 4-month rifampin-INH, 11 and continuous daily INH (≤6 years). …

… drugs rifampicin (of the rifamycin drug class) and isoniazid (… The inclusion of rifampicin and
pyrazinamide in TB regimens … per bacterium per generation for rifampicin and 2.56 x 10 8 …

… of isoniazid, rifampicin, pyrazinamide and ethambutol (2 HRZE), follow by 4 months of rifampicin
and isoniazid (4 … The present meta-analysis showed that high doses of rifampicin were …

… meta-analysis to evaluate the accuracy of the NRA for the detection of rifampicin- and isoniazid…
met our inclusion criteria for rifampicin resistance detection and 13 for isoniazid. Of these, …